The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2017

Filed:

Jul. 21, 2014
Applicants:

Frederic Zecri, Brookline, MA (US);

Philipp Grosche, Inzlingen, DE;

Kayo Yasoshima, Cambridge, MA (US);

Hongjuan Zhao, Lexington, MA (US);

Jun Yuan, Boston, MA (US);

Inventors:

Frederic Zecri, Brookline, MA (US);

Philipp Grosche, Inzlingen, DE;

Kayo Yasoshima, Cambridge, MA (US);

Hongjuan Zhao, Lexington, MA (US);

Jun Yuan, Boston, MA (US);

Assignee:

NOVARTIS AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); C07K 7/50 (2006.01); A61K 38/10 (2006.01); C07K 7/04 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); A61K 38/08 (2006.01); A61K 45/06 (2006.01); C07K 7/06 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 45/06 (2013.01); C07K 7/06 (2013.01); C07K 14/47 (2013.01);
Abstract

The invention provides a synthetic polypeptide of Formula I': X1-R-P-R-X5-X6-X7-K-X9-P-X11-X12-X13 or an amide, an ester, a salt or a bioconjugate thereof, wherein X1, X5, X6, X7, X9 and X11 to X13 are defined herein. The polypeptides and bioconjugates are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides or bioconjugates of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.


Find Patent Forward Citations

Loading…